Altimmune, Inc.
Clinical-stage biopharma developing peptide therapeutics for obesity and liver diseases.
ALT | US
Overview
Corporate Details
- ISIN(s):
- US02155H1014 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 910 CLOPPER ROAD, 20878 GAITHERSBURG
- Website:
- https://altimmune.com/
- Sector:
- Manufacturing
Description
Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics. The company's primary areas of development are treatments for obesity and liver diseases, including metabolic dysfunction-associated steatohepatitis (MASH). Its lead product candidate is pemvidutide. Altimmune also develops immune-modulating therapies for a range of diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Altimmune, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Altimmune, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Altimmune, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
